Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
4.45B | 4.08B | 3.20B | 2.32B | 1.40B | Gross Profit |
1.31B | 1.29B | 1.02B | 744.66M | 471.96M | EBIT |
821.14M | 889.10M | 735.77M | 525.61M | 318.13M | EBITDA |
999.10M | 1.11B | 868.43M | 623.67M | 385.36M | Net Income Common Stockholders |
598.26M | 682.93M | 476.78M | 441.46M | 170.09M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
651.59M | 768.00M | 884.71M | 1.10B | 2.58B | Total Assets |
10.93B | 10.73B | 7.24B | 6.69B | 4.70B | Total Debt |
2.79B | 2.72B | 1.29B | 1.23B | 2.48M | Net Debt |
2.42B | 2.16B | 435.35M | 524.59M | -382.62M | Total Liabilities |
4.25B | 4.48B | 2.30B | 2.21B | 359.93M | Stockholders Equity |
6.65B | 6.23B | 4.93B | 4.46B | 4.27B |
Cash Flow | Free Cash Flow | |||
0.00 | -157.98M | 92.26M | -236.84M | -25.77M | Operating Cash Flow |
0.00 | 782.84M | 685.38M | 426.25M | 296.13M | Investing Cash Flow |
0.00 | -2.86B | -372.06M | -850.85M | -2.48B | Financing Cash Flow |
0.00 | 1.78B | -154.21M | 754.50M | 2.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | HK$9.77B | 16.02 | 9.30% | ― | 7.28% | -13.77% | |
54 Neutral | $5.31B | 3.26 | -45.10% | 2.79% | 16.76% | 0.02% | |
$525.94M | 19.12 | 1.44% | 5.58% | ― | ― | ||
$10.37B | 42.63 | 6.14% | 1.32% | ― | ― | ||
$1.88B | 87.77 | 0.96% | ― | ― | ― | ||
$7.42B | 6.95 | 9.19% | 5.60% | ― | ― | ||
€24.50M | ― | -151.78% | ― | ― | ― |
Hygeia Healthcare Holdings Co., Ltd. announced a change in its executive leadership with Ms. Cheng Huanhuan stepping down as Co-chief Executive Officer to focus on her role as an executive Director and secretary to the Board. Mr. Ren Ai has been appointed as the new Co-chief Executive Officer, bringing over 15 years of management experience from multinational corporations. This leadership change is expected to enhance the company’s operational management and strategic focus, particularly in investment, financing, and supply chain management.
Hygeia Healthcare Holdings Co., Ltd. has announced the composition of its board of directors and their respective roles within the company. This announcement outlines the leadership structure, which includes both executive and independent non-executive directors, and specifies their roles in various board committees, potentially impacting the company’s governance and strategic direction.
Hygeia Healthcare Holdings Co., Ltd. reported a 9.1% increase in revenue to RMB4,446.1 million for the year ending December 31, 2024, despite a 12.6% drop in net profit to RMB598.3 million. The company also repurchased over 11 million shares, with plans to cancel the remaining shares, and opted not to declare a final dividend for the year. The release highlights the use of non-IFRS measures to provide a clearer view of financial performance, although these measures have limitations and are not standardized across companies.
Hygeia Healthcare Holdings Co., Ltd. announced that it will hold a conference call on March 28, 2025, to present its 2024 annual results and business operations. This initiative aims to provide shareholders and potential investors with a comprehensive understanding of the company’s financial performance and operational strategies. The presentation will be accessible online, ensuring equal and timely access to information for all stakeholders.
Hygeia Healthcare Holdings Co., Ltd. has announced that its board of directors will convene on March 27, 2025, to review and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend, which could impact the company’s financial strategy and stakeholder returns.